4//SEC Filing
MacDonald James J. 4
Accession 0001562180-22-005121
CIK 0001770121other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 6:16 PM ET
Size
11.3 KB
Accession
0001562180-22-005121
Insider Transaction Report
Form 4
MacDonald James J.
See Remarks
Transactions
- Award
Common Stock
2022-05-13$4.28/sh+1,183$5,068→ 430,600 total - Exercise/Conversion
Common Stock
2022-06-13$1.48/sh+66,796$98,858→ 497,396 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-06-13−66,796→ 51,954 totalExercise: $1.48Exp: 2030-01-26→ Common Stock (66,796 underlying)
Holdings
- 7,812(indirect: By Trust)
Common Stock
- 125,000(indirect: By Trust)
Common Stock
- 125,000(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of common stock of Sana Biotechnology, Inc. (the "Issuer") pursuant to the Sana Biotechnology, Inc. 2021 Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of November 17, 2021 through May 13, 2022. This transaction is exempt under Rule 16b-3(c).
- [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on May 13, 2022.
- [F3]25% of the shares underlying the option vested and became exercisable on February 14, 2021, and the remainder of the shares underlying the option vest at a rate of 1/36th per month thereafter.
Documents
Issuer
Sana Biotechnology, Inc.
CIK 0001770121
Entity typeother
Related Parties
1- filerCIK 0001830054
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 6:16 PM ET
- Size
- 11.3 KB